
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dual blockade of EGFR and PI3K signaling pathways offers a therapeutic strategy for glioblastoma
Tongxuan Guo, Changyong Wu, Junhao Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Tongxuan Guo, Changyong Wu, Junhao Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma via RAB7B-mediated autophagy
Dan Pan, Qing Wang, Shouyi Tang, et al.
Toxicology and Applied Pharmacology (2024) Vol. 485, pp. 116906-116906
Closed Access | Times Cited: 2
Dan Pan, Qing Wang, Shouyi Tang, et al.
Toxicology and Applied Pharmacology (2024) Vol. 485, pp. 116906-116906
Closed Access | Times Cited: 2
Involvement of oncomiRs miR-23, miR-24, and miR-27 in the regulation of alternative polyadenylation in glioblastoma via CFIm25 cleavage factor
Mozhgan Foroutan Kahangi, Vahid Tavakolpour, Iman Samiei Mosleh, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 7, pp. 1269-1281
Closed Access
Mozhgan Foroutan Kahangi, Vahid Tavakolpour, Iman Samiei Mosleh, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 7, pp. 1269-1281
Closed Access
Anticancer Target Combinations: Network-Informed Signaling-Based Approach to Discovery
Bengi Ruken Yavuz, Hyunbum Jang, Ruth Nussinov
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Bengi Ruken Yavuz, Hyunbum Jang, Ruth Nussinov
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma
Maria A. Jacome, Qiong Wu, Yolanda Piña, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3635-3635
Open Access
Maria A. Jacome, Qiong Wu, Yolanda Piña, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3635-3635
Open Access
Repurposing Osimertinib and Gedatolisib for Glioblastoma Treatment: Evidence of Synergistic Effects in an In Vitro Phenotypic Study
V José, Bruno Marques Vieira, Vivaldo Moura‐Neto, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1623-1623
Open Access
V José, Bruno Marques Vieira, Vivaldo Moura‐Neto, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1623-1623
Open Access
Microtubule actin crosslinking factor 1, a brain tumor oncoprotein (Review)
Kala Bonner, Quincy Quick
Molecular and Clinical Oncology (2024) Vol. 22, Iss. 2
Open Access
Kala Bonner, Quincy Quick
Molecular and Clinical Oncology (2024) Vol. 22, Iss. 2
Open Access
Herbal drug‑based nanotherapy for hepatocellular carcinoma: Quercetin‑contained nanocarrier as a multipurpose therapeutic agent against hepatocellular carcinoma (Review)
Tserendolgor Batsukh, Altansukh Tsend-Ayush
Biomedical Reports (2024) Vol. 22, Iss. 2
Open Access
Tserendolgor Batsukh, Altansukh Tsend-Ayush
Biomedical Reports (2024) Vol. 22, Iss. 2
Open Access